Medical Xpress news

Medical Xpress / New drug could boost efforts to wipe out sleeping sickness

A new treatment for sleeping sickness could make it much easier to treat and possibly eliminate the deadly disease.

Mar 2, 2026 in
Medical Xpress / Precision tumor imaging with a fluorescence probe and engineered enzymes—selective activation enables easy visibility

Cancer is a universal issue which affects many people around the world. Many will turn to surgery in the hope a surgeon will be able to completely remove a tumor, leaving healthy tissues unaffected. Various tools and techniques ...

Mar 2, 2026 in
Medical Xpress / Novel prosthetic design combines AI and 3D printing to improve fit

A new, fully customizable 3D printed socket design is set to transform the prosthetics industry. The reimagined limb socket interface combines highly personalized pressure mapping with AI software and a lighter infill, creating ...

Mar 2, 2026 in
Medical Xpress / The research that got sick veterans treatment

When Congress passed the Promise to Address Comprehensive Toxics (PACT) Act in 2022, it brought long-overdue relief to veterans denied benefits because there wasn't enough scientific evidence tying burn pit exposure to their ...

Mar 2, 2026 in
Medical Xpress / Statins, diuretics, and other common heart drugs do not worsen survival in multiple myeloma, scientists report

Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, according to new international ...

Mar 2, 2026 in
Medical Xpress / Targeted PET/CT predicts early treatment response in rheumatoid arthritis patients

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of ...

Mar 2, 2026 in
Medical Xpress / International mpox trial finds no clinical benefit from tecovirimat

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox compared with placebo, ...

Mar 2, 2026 in
Medical Xpress / Hormones influence women's exercise performance, but not as you'd expect, finds research

Female sex hormones estrogen and progesterone fluctuate monthly across the menstrual cycle, affecting moods and energy levels. New research from the University of Oregon finds that those fluctuations don't change a woman's ...

Mar 2, 2026 in
Medical Xpress / Science of fitting in: Do best friends or popular peers shape teen behavior?

As children enter adolescence, peers become a dominant force in their lives. With adult supervision waning, teens look to agemates for guidance on how to act, think, and fit in. But who matters most—friends or the popular ...

Mar 2, 2026 in
Medical Xpress / Free 10‑minute online programs aimed at overcoming depression led to real improvements: New research

A well-designed 10-minute online exercise can spark small reductions in depression. That's the key finding of my team's paper, published in Nature Human Behaviour.

Mar 2, 2026 in
Medical Xpress / Babies exposed to poverty show delays in motor development as early as six months

Poverty can affect babies' motor development as early as six months of age. This is the conclusion of the first Brazilian study to examine the quantity and quality of motor development month by month and its relationship ...

Mar 2, 2026 in
Medical Xpress / Foundation AI model uses MRI data to predict multiple brain disorders

Artificial intelligence (AI) systems are computational models that can learn to identify patterns in data, make accurate predictions or generate content (e.g., texts, images, videos or sound recordings). These models can ...

Mar 1, 2026 in